Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P15088 (
mast cell
)
14,925
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Human eosinophil granule major basic protein (MBP1) is an exceedingly basic (isoelectric point >11) 14-kDa protein, comprising the core of the secondary eosinophil granule. Recently, a less cationic homolog of MBP, termed MBPH or simply,
MBP2
, has been discovered. We prepared a panel of mAbs to
MBP2
and used these Abs to localize and quantitate this molecule in leukocytes and biological fluids. Specific mAbs for
MBP2
were selected using slot-blot analyses and used in a two-site immunoassay, Western blotting, and immunofluorescence microscopy. The sensitivity of the immunoassay was markedly improved by reduction and alkylation of
MBP2
. MBP1 is more abundant than
MBP2
in lysates of eosinophils and their granules, as judged by immunoassay and Western blotting. By immunofluorescence, MBP1 is present in eosinophils, basophils, and a human
mast cell
line (HMC1), whereas
MBP2
is only detected in eosinophils. Neither MBP1 nor
MBP2
could be detected in any other peripheral blood leukocyte.
MBP2
levels measured in plasma and serum were essentially identical. In contrast to past measurements for MBP1,
MBP2
was not detected above normal levels in sera from pregnant donors. However, measurement of serum
MBP2
discriminated patients with elevated eosinophils from normal subjects, and
MBP2
was also detectable in other biological specimens, such as bronchoalveolar lavage, sputum, and stool. These results indicate that
MBP2
is present only in eosinophils and that it may be a useful biomarker for eosinophil-associated diseases.
...
PMID:Major basic protein homolog (MBP2): a specific human eosinophil marker. 1708 53